Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carina Conzelmann

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Antiviral Research|August 2, 2020
An enzyme-based immunodetection assay to quantify SARS-CoV-2 infectionCarina Conzelmann, Andrea Gilg, Rüdiger Groß, et al.
Journal of Virological Methods|September 6, 2020
Rapid, convenient and efficient kit-independent detection of SARS-CoV-2 RNADetlef Michel, Karin M Danzer, Rüdiger Groß, et al.
Mbio|October 17, 2020
SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in HumansRayhane Nchioua, Dorota Kmiec, Janis A Müller, et al.
Communications Biology|July 8, 2022
Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell cultureLukas Wettstein, Philip Maximilian Knaff, Christian Kersten, et al.
Cellular and Molecular Gastroenterology and Hepatology|November 13, 2020
Drug Inhibition of SARS-CoV-2 Replication in Human Pluripotent Stem Cell-Derived Intestinal OrganoidsJana Krüger, Rüdiger Groß, Carina Conzelmann, et al.
Journal of Medical Virology|September 3, 2022
Native and activated antithrombin inhibits TMPRSS2 activity and SARS-CoV-2 infectionLukas Wettstein, Patrick Immenschuh, Tatjana Weil, et al.
Frontiers in Pediatrics|April 13, 2023
Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infectionAlina Seidel, Eva-Maria Jacobsen, Dorit Fabricius, et al.
Ebiomedicine|December 20, 2021
Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variantsRüdiger Groß, Michelle Zanoni, Alina Seidel, et al.
Frontiers in Immunology|August 12, 2022
BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA.1 in young adultsAlina Seidel, Michelle Zanoni, Rüdiger Groß, et al.
Biomolecules|October 29, 2020
New Antibacterial Peptides from the Freshwater Mollusk <i>Pomacea poeyana</i> (Pilsbry, 1927)Melaine González García, Armando Rodríguez, Annia Alba, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Antiviral Research|August 2, 2020
An enzyme-based immunodetection assay to quantify SARS-CoV-2 infectionCarina Conzelmann, Andrea Gilg, Rüdiger Groß, et al.
Journal of Virological Methods|September 6, 2020
Rapid, convenient and efficient kit-independent detection of SARS-CoV-2 RNADetlef Michel, Karin M Danzer, Rüdiger Groß, et al.
Mbio|October 17, 2020
SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in HumansRayhane Nchioua, Dorota Kmiec, Janis A Müller, et al.
Communications Biology|July 8, 2022
Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell cultureLukas Wettstein, Philip Maximilian Knaff, Christian Kersten, et al.
Cellular and Molecular Gastroenterology and Hepatology|November 13, 2020
Drug Inhibition of SARS-CoV-2 Replication in Human Pluripotent Stem Cell-Derived Intestinal OrganoidsJana Krüger, Rüdiger Groß, Carina Conzelmann, et al.
Journal of Medical Virology|September 3, 2022
Native and activated antithrombin inhibits TMPRSS2 activity and SARS-CoV-2 infectionLukas Wettstein, Patrick Immenschuh, Tatjana Weil, et al.
Frontiers in Pediatrics|April 13, 2023
Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infectionAlina Seidel, Eva-Maria Jacobsen, Dorit Fabricius, et al.
Ebiomedicine|December 20, 2021
Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variantsRüdiger Groß, Michelle Zanoni, Alina Seidel, et al.
Frontiers in Immunology|August 12, 2022
BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA.1 in young adultsAlina Seidel, Michelle Zanoni, Rüdiger Groß, et al.
Biomolecules|October 29, 2020
New Antibacterial Peptides from the Freshwater Mollusk <i>Pomacea poeyana</i> (Pilsbry, 1927)Melaine González García, Armando Rodríguez, Annia Alba, et al.
Pageof 3